Carmichael S. L., et al. Maternal progestin intake and risk of hypospadias. Arch. Pediatr. Adolesc. Med., 2005; 159:957–962.
Carp H. Cytokines in recurrent miscarriage. Lupus, 2004; 13:630–634.
Carson-Jurica M. A., Schrader W. T., O’Malley B. W. Steroid receptor family: structure and functions. Endocr. Rev., 1990; 11:201–220.
Case A. M., Reid R. L. Effects of the menstrual cycle on medical disorders. Arch. Inter. Med., 1998; 158:1405–1412.
Casey M. L., MacDonald P. C. Formation of deoxycorticosterone from progesterone in extraadrenal tissues: demonstration of steroid 21-hydroxylase activity in human aorta. J. Clin. Endocrinol. Metab., 1982; 55:804–806.
Casey M. L., Winkel C. A., MacDonald P. C. Conversion of progesterone to deoxycorticosterone in the human fetus: steroid 21-hydroxyase activity in fetal tissues. J. Steroid. Biochem., 1983; 18:449–452.
Cassidenti D. L., et al. Ef fects of sex steroids on skin 5 alpha-reductase activity in vitro. Obstet. Gynecol., 1991; 78:103–107.
Casson P., et al. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am. J. Obstet. Gynecol., 1990; 162:99–105.
Catt K. J. ABC of endocrinology. I. Hormones in general. Lancet, 1970; 1:763–765.
Caufriez A., et al. Progesterone Prevents Sleep Disturbances and Modulates GH, TSH, and Melatonin Secretion in Postmenopausal Women. J. Clin. Endocrinol. Metab., 2011;96:E614–E623.
Cauley J. A., et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA, 2003; 290:1729–1738.
Cavagna M., Mantese J. C. Biomarkers of endometrial receptivity — a review. Placenta, 2003; 24 (Suppl B):S39–S47.
Celayir S., Ilce Z., Dervisoglu S. The sex hormone receptors in the bladder in childhood, I: preliminary report in male subjects. Eur. J. Pediatr. Surg., 2002; 12:312–317.
Chabbert-Buffet N., et al. Selective progesterone receptor modulator and progesterone antagonist: mechanism of action and clinical application. Hum. Reprod. Update, 2005; 11:293–307.
Chaffin C. L., Hess D. L., Stouffer R. L. Dynamics of periovulatory steroidogenesis in the rhesus monkey follicle after controlled ovarian stimulation. Hum. Reprod., 1999; 14:642–649.
Chaffin C. L., Stouffer R. L. Expression of matrix metalloproteinases and their tissue inhibitor messenger ribonucleic acids in macaque periovulatory granulose cells: time course and steroid regulation. Biology of Reproduction, 1999; 61:14–21.
Champagne J., et al. Progesterone and Cerebral Function during Emotion Processing in Men and Women with Schizophrenia. Hindawi Publishing Corporation, Schizophrenia Research and Treatment, 2012; 6.
Chang R. J. Polycystic ovaries in 2001:physiology and treatment. J. Gynecol. Obstet. Biol. Reprod. (Paris), 2002; 31:1S15–1S19.
Channing C. P., et al. Hormonal control of oocyte meiosis, ovulation and luteinization in mammals. Clin. Endocrinol. Metab., 1978; 7 (3):601–24.
Channing C. P., et al. Ovarian follicular and luteal physiology. Int. Rev. Physiol.,1980; 22:117–201.
Chantilis S. J., et al. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil. Steril., 1999; 72:823–829.
Chao K. H., et al. Decidual natural killer cytotoxity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion. Am. J. Reprod. Immunol., 1995; 34:274–280.
Chaouat G., et al. A brief review of recent data on some cytokine expressions at the materno-foetal interface that might challenge the classical Th-1/Th-2 dichotomy. J. Reprod. Immunol., 2002; 53:241–256.
Charlesworth D. Plant sex determination and sex chromosomes. Heredity, 2002; 88:94–101.
Check J. H., et al. Evidence that high serum progesterone (P) levels on day of human chorionic gonadotropin (hCG) injection have no adverse effect on the embryo itself as determined by pregnancy outcome following embryo transfer using donated eggs. Clin. Exp. Obstet. Gynecol., 2010; 37:179–180.
Check J. H., et al. Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program. Fertil. Steril., 1994; 61:262–264.
Check J. H., et al. Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters. Int. J. Fertil., 1987; 33:192–199.
Check J. H., Rankin A., Teichman M. The risk of fetal anomalies as a result of progesterone therapy during pregnancy. Fertil. Steril., 1986; 45:575–577.
Check J. H. Th1 and Th2 cytokine profiles in recurrent aborters may merely reflect progesterone status. Hum. Reprod., 2002; 17:1669–1674.
Cheng C. M., et al. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J., 2001; 15:907–915.
Cheremisinoff N. P., King J. A., Boyko R. Dangerous Properties of Industrial and Consumer Chemicals. M. Dekker, 1994:779.